Atlas Brown’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-2,280
| Closed | -$209K | – | 238 |
|
|
2026
Q2 | $209K | Buy |
+2,280
| New | +$199K | 0.06% | 231 |
|
|
2025
Q3 | – | Sell |
-2,373
| Closed | -$216K | – | 228 |
|
|
2025
Q2 | $216K | Hold |
2,373
| – | – | 0.07% | 206 |
|
|
2025
Q1 | $222K | Sell |
2,373
-27
| -1% | -$2.42K | 0.08% | 193 |
|
|
2024
Q4 | $218K | Hold |
2,400
| – | – | 0.07% | 197 |
|
|
2024
Q3 | $249K | Buy |
2,400
+11
| +0.5% | +$1.12K | 0.09% | 183 |
|
|
2024
Q2 | $232K | Buy |
2,389
+15
| +0.6% | +$1.38K | 0.08% | 186 |
|
|
2024
Q1 | $214K | Buy |
+2,374
| New | +$201K | 0.08% | 190 |
|
|
2022
Q1 | – | Sell |
-2,372
| Closed | -$202K | – | 190 |
|
|
2021
Q4 | $202K | Buy |
+2,372
| New | +$185K | 0.08% | 187 |
|
|
2021
Q1 | – | Sell |
-2,371
| Closed | -$203K | – | 172 |
|
|
2020
Q4 | $203K | Buy |
+2,371
| New | +$196K | 0.11% | 158 |
|
|
2018
Q4 | – | Sell |
-19,356
| Closed | -$1.3M | – | 142 |
|
|
2018
Q3 | $1.3M | Buy |
19,356
+1
| +0% | +$67 | 0.8% | 45 |
|
|
2018
Q2 | $1.27M | Hold |
19,355
| – | – | 0.3% | 44 |
|
|
2018
Q1 | $1.39M | Hold |
19,355
| – | – | 0.25% | 41 |
|
|
2017
Q4 | $1.49M | Hold |
19,355
| – | – | 0.27% | 37 |
|
|
2017
Q3 | $1.41M | Hold |
19,355
| – | – | 0.3% | 37 |
|
|
2017
Q2 | $1.44M | Buy |
19,355
+1,490
| +8% | +$111K | 1.26% | 27 |
|
|
2017
Q1 | $1.31M | Sell |
17,865
-90
| -0.5% | -$6.3K | 1.03% | 28 |
|
|
2016
Q4 | $1.33M | Hold |
17,955
| – | – | 0.55% | 25 |
|
|
2016
Q3 | $1.33M | Hold |
17,955
| – | – | 0.55% | 25 |
|
|
2016
Q2 | $1.31M | Buy |
17,955
+90
| +0.5% | +$6.41K | 0.53% | 25 |
|
|
2016
Q1 | $1.26M | Hold |
17,865
| – | – | 0.53% | 28 |
|
|
2015
Q4 | $1.15M | Hold |
17,865
| – | – | 0.73% | 25 |
|
|
2015
Q3 | $1.13M | Hold |
17,865
| – | – | 0.49% | 31 |
|
|
2015
Q2 | $1.23M | Buy |
17,865
+625
| +4% | +$42.4K | 0.48% | 29 |
|
|
2015
Q1 | $1.2M | Hold |
17,240
| – | – | 0.32% | 29 |
|
|
2014
Q4 | $1.19M | Hold |
17,240
| – | – | 0.32% | 34 |
|
|
2014
Q3 | $1.12M | Buy |
17,240
+40
| +0.2% | +$2.64K | 0.42% | 32 |
|
|
2014
Q2 | $1.17M | Hold |
17,200
| – | – | 0.58% | 25 |
|
|
2014
Q1 | $1.12M | Hold |
17,200
| – | – | 0.6% | 25 |
|
|
2013
Q4 | $1.12M | Hold |
17,200
| – | – | 0.79% | 16 |
|
|
2013
Q3 | $1.02M | Hold |
17,200
| – | – | 0.76% | 18 |
|
|
2013
Q2 | $985K | Buy |
+17,200
| New | +$1.02M | 0.21% | 53 |
|
Other funds holding CL
Atlas Brown's CL Position: Q3 2026 in Review
Atlas Brown sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 2,280 shares — an estimated $209K sold.
Atlas Brown first reported a position in CL in Q2 2013 and held it in 31 quarters. The position peaked at $1.49M in Q4 2017. 495 funds tracked by Wall St. Rank hold CL as of Q3 2026.
- Atlas Brown reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
- Atlas Brown sold 2,280 Colgate-Palmolive shares in Q3 2026, an estimated $209K.
- Atlas Brown first reported a position in Colgate-Palmolive in Q2 2013 and held it in 31 quarters.
- Atlas Brown's Colgate-Palmolive position peaked at $1.49M in Q4 2017.
- 495 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.
Based on Atlas Brown's 13F filing for Q3 2026, filed 9 Oct 2026.